Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Equity (2019 - 2025)

Historic Return on Equity for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Q3 2025 value amounting to 0.29%.

  • Arcturus Therapeutics Holdings' Return on Equity fell 500.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.31% for FY2024, which is 2000.0% down from last year.
  • According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Return on Equity is 0.29%, which was down 500.0% from 0.26% recorded in Q2 2025.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Return on Equity peaked at 0.38% during Q1 2023, and registered a low of 0.95% during Q1 2022.
  • Moreover, its 5-year median value for Return on Equity was 0.29% (2025), whereas its average is 0.33%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 13300bps in 2023, then tumbled by -7700bps in 2024.
  • Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' Return on Equity stood at 0.83% in 2021, then soared by 106bps to 0.05% in 2022, then plummeted by -310bps to 0.11% in 2023, then tumbled by -202bps to 0.32% in 2024, then rose by 9bps to 0.29% in 2025.
  • Its Return on Equity stands at 0.29% for Q3 2025, versus 0.26% for Q2 2025 and 0.29% for Q1 2025.